This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bandyopadhyay, D. Articles by Medrano, E. E. Search for Related Content PubMed PubMed Citation Articles by Bandyopadhyay, D. Articles by Medrano, E. E.

Down-Regulation of p300/CBP Histone Acetyltransferase Activates a Senescence Checkpoint in Human Melanocytes¹

Huffington Center on Aging and Departments of Molecular and Cellular Biology and Dermatology, Baylor College of Medicine, Houston, Texas 77030 [D. B., N. A. O., E. B., L. N., E. E. M.], and Department of Pharmacology and Molecular Sciences, The Johns Hopkins University, Baltimore, Maryland 21205 [P. A. C.]

The histone acetyltransferases p300 and cAMP-responsive element-binding protein-binding protein (CBP) are required for the execution of critical biological functions such as proliferation, differentiation, and apoptosis. Both proteins are believed to regulate the activity of a large number of general and cell-specific transcription factors. Here we demonstrate a dramatic decrease in the total cellular levels of p300 and CBP with increasing population doublings of human normal melanocytes. We show that one consequence of p300 depletion is transcriptional down-regulation of the cyclin E gene, caused by deacetylation of histones at its promoter. The cyclin E promoter was activated by p300 and the histone deacetylase inhibitor trichostatin A. Conversely, the cyclin E promoter was repressed by wild-type Retinoblastoma tumor suppressor p105 protein (pRB) and by a dominant negative p300 mutant (DN p300) that lacks histone acetyltransferase activity. We also provide evidence of the alternative recruitment of p300 and histone deacetylase 1 to the cyclin E promoter in proliferating and senescent melanocytes, respectively. The biological significance of these results was established by showing that block of p300 activity by overexpression of DN p300 or by Lys-CoA, a specific chemical inhibitor of p300, resulted in growth inhibition, down-regulation of cyclin E, and activation of the senescence-associated ß-galactosidase marker in human melanocytes and melanoma cells. Together, these results provide evidence for the essential role of p300 in the regulation of proliferation and senescence in cells from melanocytic origin.

This article has been cited by other articles:

				B. Karanam, L. Jiang, L. Wang, N. L. Kelleher, and P. A. Cole Kinetic and Mass Spectrometric Analysis of p300 Histone Acetyltransferase Domain Autoacetylation J. Biol. Chem., December 29, 2006; 281(52): 40292 - 40301. [Abstract] [Full Text] [PDF]

				S. El Messaoudi, E. Fabbrizio, C. Rodriguez, P. Chuchana, L. Fauquier, D. Cheng, C. Theillet, L. Vandel, M. T. Bedford, and C. Sardet Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene PNAS, September 5, 2006; 103(36): 13351 - 13356. [Abstract] [Full Text] [PDF]

				L. Stimson, M. G. Rowlands, Y. M. Newbatt, N. F. Smith, F. I. Raynaud, P. Rogers, V. Bavetsias, S. Gorsuch, M. Jarman, A. Bannister, et al. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity Mol. Cancer Ther., October 1, 2005; 4(10): 1521 - 1532. [Abstract] [Full Text] [PDF]

				T. Bouras, M. Fu, A. A. Sauve, F. Wang, A. A. Quong, N. D. Perkins, R. T. Hay, W. Gu, and R. G. Pestell SIRT1 Deacetylation and Repression of p300 Involves Lysine Residues 1020/1024 within the Cell Cycle Regulatory Domain 1 J. Biol. Chem., March 18, 2005; 280(11): 10264 - 10276. [Abstract] [Full Text] [PDF]

				D. Bandyopadhyay, A. Mishra, and E. E. Medrano Overexpression of Histone Deacetylase 1 Confers Resistance to Sodium Butyrate-Mediated Apoptosis in Melanoma Cells through a p53-Mediated Pathway Cancer Res., November 1, 2004; 64(21): 7706 - 7710. [Abstract] [Full Text] [PDF]

				M R K Dasu, R E Barrow, H K Hawkins, and R L McCauley Gene expression profiles of giant hairy naevi J. Clin. Pathol., August 1, 2004; 57(8): 849 - 855. [Abstract] [Full Text] [PDF]

				J. D. Debes, T. J. Sebo, C. M. Lohse, L. M. Murphy, D. A. L. Haugen, and D. J. Tindall p300 in Prostate Cancer Proliferation and Progression Cancer Res., November 15, 2003; 63(22): 7638 - 7640. [Abstract] [Full Text] [PDF]

				S. I. Wells, B. J. Aronow, T. M. Wise, S. S. Williams, J. A. Couget, and P. M. Howley Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells PNAS, June 10, 2003; 100(12): 7093 - 7098. [Abstract] [Full Text] [PDF]